2014
DOI: 10.1186/1471-2334-14-392
|View full text |Cite
|
Sign up to set email alerts
|

Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio choleraeO1

Abstract: BackgroundAlthough endemic cholera causes significant morbidity and mortality each year in Nepal, lack of information about the causal bacterium often hinders cholera intervention and prevention. In 2012, diarrheal outbreaks affected three districts of Nepal with confirmed cases of mortality. This study was designed to understand the drug response patterns, source, and transmission of Vibrio cholerae associated with 2012 cholera outbreaks in Nepal.MethodsV. cholerae (n = 28) isolated from 2012 diarrhea outbrea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
38
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(41 citation statements)
references
References 50 publications
3
38
0
Order By: Relevance
“…1; Supplementary Table S1). It could be hypothesized that V. cholerae strains with the short VSP-II may have a selection advantage over those with typical VSP-II, as we observed that strains with the short VSP-II had been circulated and become predominant in the 2007-2010 cholera endemic seasons and epidemic areas (13,(28)(29)(30)(31).…”
Section: Discussionmentioning
confidence: 76%
See 1 more Smart Citation
“…1; Supplementary Table S1). It could be hypothesized that V. cholerae strains with the short VSP-II may have a selection advantage over those with typical VSP-II, as we observed that strains with the short VSP-II had been circulated and become predominant in the 2007-2010 cholera endemic seasons and epidemic areas (13,(28)(29)(30)(31).…”
Section: Discussionmentioning
confidence: 76%
“…It is important to note that this short VSP-II was identified in strains isolated from many concurrent outbreaks in 2008-2010 seasons in many Asian countries, Bangladesh, Pakistan, Nepal, and Thailand, and marked a global transmission of the short VSP-II (5,28,29). In wave 3, the typical VSP-II was displaced by CIRS101 VSP-II and the short VSP-II in many endemic areas in Nepal, Pakistan, Bangladesh and Haiti (13,(28)(29)(30)(31). Imamura et al examined 79 V. cholerae O1 strains of wave 3 and found that after 2010, the typical VSP-II was completely replaced by CIRS101 VSP-II in cholera Negative 66 9 96 2 4 Total 70 9 96 2 11 †O1 pre-seventh pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…The V . cholerae O1 variants were later reported in several countries in Africa and Asia [1619]. Since 2013, after the containment of the cholera outbreak in Haiti, the number of reported cholera cases has decreased globally.…”
Section: Introductionmentioning
confidence: 99%
“…Although surveillance systems to monitor DR cholera are poor, resistance to first-line therapies such as tetracycline derivatives, ciprofloxacin, and chloramphenicol is prevalent in some geographical regions (12)(13)(14). Lower rates of resistance to azithromycin, potentially contributing to the drug's superior efficacy against cholera diarrhea in clinical trials, have been reported (15,16).…”
Section: Discussionmentioning
confidence: 99%